TMP/SMX is named as a drug or biological intervention in 2 clinical trials in our USA and China trial registers, 1 of which is recruiting. Lead sponsors include Locus Biosciences (1) and Second Affiliated Hospital, Zhejiang University, School of Medicine (1). Registered phases: Phase 2 and Not applicable. Conditions studied include Urinary Tract Infections; Chronic Obstructive Pulmonary Disease (COPD).
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT05488340 | A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) (ClinicalTrials.gov ↗) Urinary Tract Infections |
Phase 2 | Recruiting |
| NCT07665359 | Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD (ClinicalTrials.gov ↗) Chronic Obstructive Pulmonary Disease (COPD) |
Not applicable | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Urinary Tract Infections | 1 |
| Chronic Obstructive Pulmonary Disease (COPD) | 1 |
| Lead sponsor | Trials |
|---|---|
| Locus Biosciences | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Register | TMP/SMX trials |
|---|---|
| Clinical trials in USA | 1 |
| Clinical trials in China | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how TMP/SMX works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists TMP/SMX (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.